Treatment of aggression with risperidone in children and adolescents with bipolar disorder: A case series

Bipolar Disorders

Volumn 8, Issue 4, 2006, Pages 405-410

  Saxena, Kirti ^a   Chang, Kiki ^a   Steiner, Hans ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Aggression; Atypical antipsychotic; Bipolar disorder; Mania; Pediatric; Risperidone

Indexed keywords

AMPHETAMINE; CITALOPRAM; CLONIDINE; DEXAMPHETAMINE; FLUOXETINE; GABAPENTIN; LITHIUM SALT; METHYLPHENIDATE; MOOD STABILIZER; OLANZAPINE; PAROXETINE; RISPERIDONE; SERTRALINE; TRAZODONE; VALPROATE SEMISODIUM; VENLAFAXINE;

ADD ON THERAPY; ADOLESCENT; AGGRESSION; AKATHISIA; ARTICLE; BIPOLAR DISORDER; CASE STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE CONTROL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; INCREASED APPETITE; MALE; MANIA; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SEDATION; SOMNOLENCE;

ADOLESCENT; AGGRESSION; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; RETROSPECTIVE STUDIES; RISPERIDONE;

EID: 33746109588     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2006.00334.x     Document Type: Article

References (21)

1. Biederman J, Mick E, Faraone SV et.al. Pediatric mania: A developmental subtype of bipolar disorder ? Biol Psychiatry 2000; 48: 458-466.
2. Wozniak J, Biederman J, Richards JA. Diagnostic and therapeutic dilemmas in the management of pediatric-onset bipolar disorder. J Clin Psychiatry 2001; 62 (Suppl. 14): 10-15.
3. Biederman J, Mick E, Bostic JQ, et.al. The naturalistic course of pharmacologic treatment of children with manic like symptoms: A systematic chart review. J Clin Psychiatry 1998; 59: 628-637.
4. Strober M, Schmidt-Lackner S, Freeman R et.al. Recovery and relapse in adolescents with bipolar affective illness: A five-year naturalistic, prospective follow-up. J Am Acad Child Adolesc Psychiatry 1995; 34: 724-731.
5. Geller B, Craney JL, Bolhofner K, Nickelsburg MJ, Williams M, Zimerman B. Two-year prospective follow-up of children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry 2002; 159: 927-933.
6. DeLong GR, Aldershof AL. Long-term experience with lithium treatment in childhood: Correlation with clinical diagnosis. J Am Acad Child Adolesc Psychiatry 1987; 26: 389-394.
7. Sachs GS, Grossman F, Ghaemi SN, Okamoto A, Bowden CL. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: A double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry 2002; 159: 1146-1154.
8. Bowden CL, Myers JE, Grossman F, Xie Y. Risperidone in combination with mood stabilizers: A 10-week continuation phase study in bipolar I disorder. J Clin Psychiatry 2004; 65: 707-714.
9. Yatham LN, Grossman F, Augustyns I, Vieta E, Ravindran A. Mood stabilizers plus risperidone or placebo in the treatment of acute mania: international, double-blind, randomized controlled trial. Br J Psychiatry 2003;182: 141-147.
10. Licht RW, Bysted M, Christensen H. Fixed-dosed risperidone in mania: An open experimental trial. Int Clin Psychopharmacol 2001; 16: 103-110.
11. Khanna S, Vieta E, Lyons B, Grossman F, Eerdekens M, Kramer M. Risperidone in the treatment of acute mania: Double-blind, placebo-controlled study. Br J Psychiatry 2005; 187: 229-234.
12. Hirschfeld RMA, Keck PE, Kramer M et.al. Rapid antimanic effect of risperidone monotherapy: A 3-week multicenter, double-blind, placebo-controlled trial. Am J Psychiatry 2004; 161: 1057-1065.
13. Frazier JA, Meyer MC, Biederman J et.al. Risperidone treatment for juvenile bipolar disorder: A retrospective chart review. J Am Acad Child Adolesc Psychiatry 1999; 38: 960-965.
14. Turgay A, Binder C, Snyder R, Fisman S. Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs. Pediatrics 2002; 110: E34.
15. Simeon J, Milin R, Walker S. A retrospective chart review of risperidone use in treatment-resistant children and adolescents with psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 2002; 2: 267-275.
16. Zuddas A, DiMartino A, Muglia P, Cianchetti C. Long-term risperidone for pervasive developmental disorder: Efficacy, tolerability, and discontinuation. J Child Adolesc Psychopharmacol 2000; 10: 79-90.
17. Findling RL, Kusumakar V, Daneman D, Moshang T, De.Smedt G, Binder C. Prolactin levels during long-term risperidone treatment in children and adolescents. J Clin Psychiatry 2003; 64: 1362-1369.
18. Buitelaar JK, van der Gaag RJ, Cohen-Kettenis P, Melman CT. A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities. J Clin Psychiatry 2001;62: 239-248.
19. Aman MG, De.Smedt G, Derivan A, Lyons B, Findling RL, The Risperidone Disruptive Behavior Study Group. Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. Am J Psychiatry 2002; 159: 1337-1346.
20. McCracken JT, McGough J, Shah B et.al. Risperidone in children with autism and serious behavioral problems. N Engl J Med 2002; 347: 314-321.
21. Snyder R, Turgay A, Aman M, Binder C, Fisman S, Carroll A. Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs. J Am Acad Child Adolesc Psychiatry 2002; 41: 1026-1036.